XML 40 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 153,048,925 $ 128,988,206
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 42,334,977 37,620,512
Loss on disposal of assets 2,114,241 327,382
Gain on sale of investments (15,121,583) (8,420,229)
Loss on sale of investments 805,805 841,274
Deferred income taxes (6,271,382) 2,923,004
Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock 12,528,264 12,361,993
Excess tax benefits from stock-based compensation (2,275,233) (641,072)
Change in operating assets and liabilities:    
Accounts receivable, net (31,755,237) (15,882,832)
Inventories 42,523,707 11,633,857
Prepaid expenses and other (12,362) 4,403,912
Accounts payable 7,139,387 (13,236,250)
Accrued liabilities, excluding dividends declared 18,606,444 15,529,686
Net cash provided by operating activities 223,665,953 176,449,443
Activity in available-for-sale securities:    
Sales proceeds 69,937,242 31,564,139
Maturities and calls 98,142,408 70,652,000
Purchases (58,278,107) (63,441,410)
Plant and equipment additions (38,026,769) (97,597,283)
Proceeds from sale of plant and equipment 316,449 1,012,608
Acquisition of businesses, net of cash acquired (698,107,014) 0
(Increase) decrease in other assets (602,017) (16,036,911)
Net cash (used for) provided by investing activities (626,617,808) (73,846,857)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from borrowings on Credit Agreement 275,000,000 0
Financing costs paid (953,800) 0
Issuance of common stock from stock plan transactions 22,526,742 8,417,982
Cash dividends paid (58,898,029) (54,829,734)
Repurchases of common stock 0 (33,716,725)
Excess tax benefits from stock-based compensation 2,275,233 641,072
Net cash provided by (used for) financing activities 239,950,146 (79,487,405)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (163,001,709) 23,115,181
CASH AND CASH EQUIVALENTS, beginning of period 389,678,664 357,986,774
CASH AND CASH EQUIVALENTS, end of period $ 226,676,955 $ 381,101,955